Print this page Email this page
Users Online: 97
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Contacts Login 
Year : 2022  |  Volume : 36  |  Issue : 3  |  Page : 129-133

SARS-CoV-2 and Helicobacter pylori and some hematological parameters: A case–control study

1 Department of Medical Laboratory Technology, College of Medical Technology, The Islamic University, Najaf; Department of Microbiology, Al-Shomali General Hospital, Babylon Health Directorate, Babylon University, Babylon, Iraq
2 Department of Pharmacy, Al-Mustaqbal University College, Babylon University, Babylon, Iraq
3 Department of Medical Microbiology, College of Medicine, Babylon University, Babylon, Iraq
4 Department of Seventh Life Laboratory, Marjan Hospital, Babylon, Iraq

Correspondence Address:
Dr. Falah Hasan Obayes Al-Khikani
Department of Medical Laboratory Technology, College of Medical Technology, The Islamic University, Najaf
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/jms.jms_55_22

Rights and Permissions

Background: The SARS-CoV-2 associated with bacterial infection represents a serious public health challenge. Recently, there is a remarkable increase in the number of researches that confirms the effect of Helicobacter pylori on pulmonary diseases. Aim: The goal of this research was to see how H. pylori affected the presentation of COVID-19 infections as a prospective risk factor. Materials and Methods: This research was conducted in Babylon, Iraq, from January 1, 2022, to March 5, 2022. A total of 180 people were engaged in this study, with 90 patients identified with SARS-CoV-2 by polymerase chain reaction testing and 90 people serving as a control group. Antibody screening assays on blood samples were used to look for antibodies against H. pylori. The samples were processed for complete blood count and ABO blood group. Results: COVID-19 infection was more frequent in females than in males, especially between 31 and 45 years. When compared to healthy people, COVID-19 patients had a higher white blood cell count (P = 0.0001) and a lower lymphocyte count (P = 0.0001). H. pylori and COVID-19 have been found to have a strong relationship, especially in females. When comparing patients to healthy people, blood group A is the most common. Conclusion: People with H. pylori infections are considerably more sensitive to COVID-19 than people without H. pylori infections (P = 0.011). In combination with SARS-CoV-2, IgG for H. pylori might be a risk factor.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded28    
    Comments [Add]    

Recommend this journal